Skip to main contentAI and Advanced
/
FABTECH · NSEMarket ticker unavailable · configure an authorised index feed
FA
NSE · Equity shares · Biotechnology & Drugs0.27 · 0.19%
Fabtech Technologies FABTECH
NSE:INR 146.02
BSE:INR 149.5
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
AI analysis and Advanced tools for FABTECH
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 145.75
Day rangeINR 142.52 — INR 146.68
52-week rangeINR 132.7 — INR 262.8
Volume55,593
Market cap668.98
P/E12.68
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)410.77
Net Income (INR Cr)38.36
Rev Growth (5 Year %)27.69
EPS Growth (5 Year %)32.13
P/E Ratio12.68
EPS10
Research path: Interpret Fabtech Technologies's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
FABTECHFabtech Technologies1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 653.7 | 426.56 | 269.24 |
| Cash Equivalents | 86.88 | 0.39 | 2.15 |
| Other Liabilities Total | 1.66 | 0.82 | 0.83 |
| Long Term Debt | 0.53 | 0 | 0 |
| Common Stock Total | 44.45 | 32.39 | 2.94 |
| Other Equity Total | 375.32 | -0.48 | -0.12 |
| Other Current Assets Total | 35.19 | 1.32 | 0.39 |
| Total Assets | 653.7 | 426.56 | 269.24 |
| Current Portof LT Debt/Capital Leases | 44.21 | 2.89 | 2.4 |
| Total Equity | 419.77 | 173.11 | 131.88 |
| Long Term Investments | 41.86 | 13.27 | 0.86 |
| Total Common Shares Outstanding | 4.45 | 3.24 | 3.24 |
| Tangible Book Valueper Share Common Eq | 89.21 | 41.82 | 35.61 |
| Goodwill Net | 22.97 | 37 | 16.1 |
| Total Liabilities | 233.93 | 253.44 | 137.35 |
| Total Debt | 69.63 | 83.83 | 12.71 |
| Short Term Investments | 168.37 | 32.38 | 38.18 |
| Cashand Short Term Investments | 255.26 | 41.44 | 67.17 |
| Total Receivables Net | 204.63 | 203.52 | 132.27 |
| Accounts Receivable-Trade Net | 204.34 | 150.74 | 96.66 |
| Property/Plant/Equipment Total-Net | 54.9 | 56.49 | 5.56 |
| Minority Interest | 0 | 0 | 0 |
| Total Current Liabilities | 206.85 | 225.47 | 134.89 |
| Total Inventory | 21.34 | 59.42 | 29.27 |
| Accounts Payable | 105.37 | 98.8 | 65.06 |
| Other Currentliabilities Total | 57.26 | 69.04 | 56.96 |
| Total Long Term Debt | 25.43 | 27.15 | 1.63 |
| Intangibles Net | 0.24 | 0.65 | 0.43 |
| Other Long Term Assets Total | 9.5 | 9.62 | 14.99 |
| Note Receivable-Long Term | 7.81 | 1.12 | 1.64 |
| Total Current Assets | 516.42 | 308.41 | 229.66 |
| Capital Lease Obligations | 24.9 | 27.15 | 1.63 |
| Accumulated Depreciation Total | Not available | -10.4 | -8.1 |
| Accrued Expenses | Not available | 0.96 | 1.79 |
| Prepaid Expenses | Not available | 2.71 | 0.55 |
| Additional Paid-In Capital | Not available | 0 | 29.45 |
| Cash | Not available | 8.67 | 26.84 |
| Retained Earnings(Accumulated Deficit) | Not available | 141.2 | 99.61 |
| Property/Plant/Equipment Total-Gross | Not available | 66.89 | 13.65 |
| Notes Payable/Short Term Debt | Not available | 53.78 | 8.68 |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio0.96
Price to Sale Ratio1.63
Growth
Debt 5Yr CAGR %50.97
Margins
Operating Margin 12m7.23
Operating Margin 5y Avg10.63
Net Profit Margin 12m9.34
Net Profit Margin 5y11.12
Yield
Dividend Yield %0.4
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskHigh risk
Board Risk53.89
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | INR 1,936.5 | 4.65 L | 38.4 | — |
| Divi's Laboratories | INR 7,379.2 | 1.96 L | 73.32 | — |
| Torrent Pharmaceuticals | INR 4,982.45 | 1.69 L | 72.73 | — |
| Cipla | INR 1,405.8 | 1.14 L | 27.57 | — |
| Zydus Lifesciences | INR 1,117.85 | 1.11 L | 21.19 | — |
Shareholding
Ownership
- Promoter
- 68.94%
- FII
- 0.02%
- Other
- 31.04%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Fabtech Technologies Ltd Technical Momentum Shifts Amid Market Challenges - MarketsMojoMarket news · 22 Jul 2026, 9:12 am
Fabtech Technologies Ltd Technical Momentum Shifts Amid Market Challenges MarketsMojo
Fabtech Technologies board to consider preferential issue on July 20 - scanx.tradeMarket news · 15 Jul 2026, 9:22 pm
Fabtech Technologies board to consider preferential issue on July 20 scanx.trade
Fabtech Technologies wins ₹33.79 Crore pharma and energy orders, order book hits ₹362.41 Crore. - SahiMarket news · 14 Jul 2026, 3:21 pm
Fabtech Technologies wins ₹33.79 Crore pharma and energy orders, order book hits ₹362.41 Crore. Sahi
Fabtech Technologies Ltd is Rated Hold - MarketsMojoMarket news · 14 Jul 2026, 2:34 am
Fabtech Technologies Ltd is Rated Hold MarketsMojo
Fabtech Technologies Cleanrooms Ltd (BSE: 544332, NSE: FABCLEAN) — Business Report / Investor Feed - t.coMarket news · 12 Jul 2026, 11:42 am
Fabtech Technologies Cleanrooms Ltd (BSE: 544332, NSE: FABCLEAN) — Business Report / Investor Feed t.co
Fabtech Cleanrooms secures ₹33.79 crore orders in June 2026 - scanx.tradeMarket news · 11 Jul 2026, 6:06 pm
Fabtech Cleanrooms secures ₹33.79 crore orders in June 2026 scanx.trade
Corporate actions
Events
- board MeetingsTo consider and approve: (1) raising funds through a preferential issue of equity shares and/or convertible warrants, subject to required approvals; and (2) appointing Ms. Jai Vaidya (ACS-42246) as Company Secretary & Compliance Officer (KMP).
- annual General MeetingPOM
- dividendRs.0.6000 per share(6%)Final Dividend
- board MeetingsAudited Results & Final Dividend
- board MeetingsQuarterly Results
- board Meetings(Revised)
- board MeetingsQuarterly Results
- annual General MeetingAGM
Rusaka Markets Community
Discussion and sentiment for Fabtech Technologies
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Fabtech Technologies Ltd. is an India-based transnational pharmaceutical engineering company. It offers end-to-end solutions across the pharmaceutical, biotechnology, and healthcare sectors. The Company focuses on bio clean air, clean water, and process requirements, delivering solutions that span the entire project lifecycle for its customers. It covers various dosage forms, including liquids, solids, and semisolids, across the pharmaceutical value chain. Its turnkey engineering services encompass market analysis, disease profiling, custom equipment design, and the application of advanced technologies to project execution. Its expertise spans across executing a diverse array of projects and solutions, including granulation solutions, isolator containment systems, injectable projects, encapsulation solutions, cleanroom infrastructure, cleanroom systems, cleanroom equipment, heating, ventilation, and air conditioning systems, mechanical, electrical and plumbing and packaging lines.
Company facts
- Industry
- Biotechnology & Drugs
- Sector
- Biotechnology & Drugs
- NSE Code
- FABTECH
- BSE Code
- 544558
Questions
Stock FAQ
What is the symbol and ISIN of Fabtech Technologies?
Fabtech Technologies has the symbol FABTECH and ISIN - INE0HF201011.
What is the current price of Fabtech Technologies?
Fabtech Technologies is currently trading at INR 146.02.
What are the year high and year low of Fabtech Technologies?
Fabtech Technologies has a year high of INR 262.80 and a year low of INR 132.70.
What is the market capitalization of Fabtech Technologies?
Fabtech Technologies has a market capitalization of INR 668.98 crore.
What is the P/E ratio of Fabtech Technologies?
Fabtech Technologies has a P/E ratio of 12.68.
What is the dividend yield of Fabtech Technologies?
Fabtech Technologies has a dividend yield of 0.40%.
How is the financial performance of Fabtech Technologies based on revenue, net income, and EPS?
Fabtech Technologies has revenue of INR 410.77 crore, net income of INR 38.36 crore, and EPS of INR 10.98.
What is the book value of Fabtech Technologies?
Fabtech Technologies has a book value of NA.
What is the debt-to-equity ratio of Fabtech Technologies?
Fabtech Technologies has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Fabtech Technologies?
Fabtech Technologies has a price-to-book ratio of NA and a price-to-sales ratio of 1.63.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.